Bot Detector

Archives of Science and Technology for the Hospital Pharmacist

Newsletter Subject
Vol. 6 No. 4 Sterility Testing
Vol. 6 No. 3 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Vol. 6 No. 2 3D Printing: Pharmacy Applications, Part 2: Technologies
Vol. 6 No. 1 3D Printing: Pharmacy Applications, Part 1: Introduction and Applications
Vol. 5 No. 6 Mixing Solids: Random vs Ordered Mixing, Part II
Vol. 5 No. 5 Mixing Solids: Random vs Ordered Mixing, Part I
Vol. 5 No. 4 Blending/Mixing in Liquids in Compounding Dosage Forms
Vol. 5 No. 3 Blending/Mixing of Solids in Liquids in Compounding Dosage Forms
Vol. 5 No. 2 Particle Size Evaluation
Vol. 5 No. 1 Blending/Mixing of Solid Dosage Forms
Vol. 4 No. 10 Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations
Vol. 4 No. 9 Redispensing Compounded and Repackaged Medications within a Health System
Vol. 4 No. 8 Use of Expired Medications During Drug Product Shortages
Vol. 4 No. 7 Does Your Drug Expertise Include Clinical Pharmaceutics?
Vol. 4 No. 6 Method Validation
Vol. 4 No. 5 Cold Reconstitution of Unstable Drugs
Vol. 4 No. 4 Stability-indicating Assays
Vol. 4 No. 3 QUALITY CONTROL: Refractive Index IV: Implementation
Vol. 4 No. 2 QUALITY CONTROL: Refractive Index III: Controlled Drug Substances
Vol. 3 No 12 QUALITY CONTROL: Refractive Index II: Osmolarity
Vol. 3 No. 11 QUALITY CONTROL: Refractive Index I: Parenteral Nutrition Solution
Vol. 4 No. 1 3% Sodium Intravenous Infusion
Vol. 3 No. 10 What's in a Nonproprietary Drug (Generic) Name?
Vol. 3 No. 9 The Biopharmaceutics Classification System and Compounding Pharmacy, Part II
Vol. 3 No. 8 The Biopharmaceutics Classification System and Compounding Pharmacy, Part I
Vol. 3 No. 7 Calculating the Endotoxin Load in Compounded Sterile Preparations
Vol. 3 No. 6 Application of United States Pharmacopeia Monographs to Manufacturing and Compounding
Vol. 3 No. 5 Role of the United States Pharmacopeia in Pharmacy Practice
Vol. 3 No. 4 An Overview of United States Pharmacopeia Sterility Testing
Vol. 3 No. 3 Potency and Stability Testing
Vol. 3 No. 2 What Kind of Drugs Are You Dispensing or Selling?
Vol. 3 No. 1 End-preparation Assessments and Tests for Compounded Sterile Preparations
Vol. 2 No. 11 Pros and Cons of Using Bulk Chemicals to Compound
Vol. 2 No. 10 Hazardous Compounding in Health Systems
Vol. 2 No. 9 It is NOT Just About Sterile Compounding! OR What About Nonsterile Compounding?
Vol. 2 No. 8 How It All Gets Absorbed
Vol. 2 No. 7 Basics of Compounding With Organic Salts
Vol. 2 No. 6 Unit-dose Packaging
Vol. 2 No. 5 Beyond-use Date: Establishment and Maintenance
Vol. 2 No. 4 Compounding with Commercial Drug Products Can Cause Errors!
Vol. 2 No. 3 Compounding Information Resources
Vol. 2 No. 2 General Guidelines/Summary for Compatibility (Solubility) and Chemical Stability
Vol. 2 No. 1 The ps in Therapeutics
Vol. 1 No. 8 pH and Solubility, Stability, and Absorption, Part II
Vol. 1 No. 7 pH and Solubility, Stability, and Absorption, Part I
Vol. 1 No. 6 Packaging/Container Issues: Unit-dose, Pre-filled Syringes, Pre-packs, Etc.
Vol. 1 No. 5 Potential Problems in Compounding for Pediatric Patients
Vol. 1 No. 4 Documentation of Potential Problems in Compounding with Manufactured Products
Vol. 1 No. 3 Beyond-Use Dates, Part 3
Vol. 1 No. 2 Beyond-Use Dates, Part 2
Vol. 1 No. 1 Beyond-Use Dates, Part 1